Get started
Author

Hajime Sakuma

Observed institution: Kameda Medical Center
ORCID: 0009-0001-1833-5509
Observed ORCID: 0009-0001-1833-5509
OpenAlex ID: A5128818119
Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton’s tyrosine kinase inhibitor and bispecific antibody therapy
2026 · Mitsuaki Oura, Masanori Toho, et al. · Frontiers in Oncology · 2
PDF
Soluble BCMA Defines Spatial Phenotypes and Prognosis in Newly Diagnosed Multiple Myeloma
2026 · Masanori Toho, Rikako Tabata, et al. · Blood
Treatment‐specific differences in soluble B‐cell maturation antigen levels at minimum residual disease negativity in multiple myeloma
2026 · Masanori Toho, Rikako Tabata, et al. · British Journal of Haematology
Clinical and radiological prediction models for random skin biopsy positivity in suspected intravascular large B-cell lymphoma: development and internal validation
2025 · Hajime Sakuma, Kentaro Narita, et al. · Leukemia & lymphoma/Leukemia and lymphoma
Works count: 4
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type